» Articles » PMID: 38132942

Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2023 Dec 22
PMID 38132942
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic modifications, mainly aberrant DNA methylation, have been shown to silence the expression of genes involved in epigenetic diseases, including cancer suppression genes. Almost all conventional cancer therapeutic agents, such as the DNA hypomethylation drug 5-aza-2-deoxycytidine, have insurmountable side effects. To investigate the role of the well-known DNA protectant (ectoine) in skin cell DNA methylation and cancer cell proliferation, comprehensive methylome sequence analysis, 5-methyl cytosine (5mC) analysis, proliferation and tumorigenicity assays, and DNA epigenetic modifications-related gene analysis were performed. The results showed that extended ectoine treatment globally hypomethylated DNA in skin cells, especially in the CpG island (CGIs) element, and 5mC percentage was significantly reduced. Moreover, ectoine mildly inhibited skin cell proliferation and did not induce tumorigenicity in HaCaT cells injected into athymic nude mice. HaCaT cells treated with ectoine for 24 weeks modulated the mRNA expression levels of , , , , , , , , , , and . Overall, ectoine mildly demethylates DNA in skin cells, modulates the expression of epigenetic modification-related genes, and reduces cell proliferation. This evidence suggests that ectoine is a potential anti-aging agent that prevents DNA hypermethylation and subsequently activates cancer-suppressing genes.

Citing Articles

Unlocking Ectoine's Postbiotic Therapeutic Promise: Mechanisms, Applications, and Future Directions.

Xingrong L, Gorish B, Qaria M, Hussain A, Abdelmula W, Zhu D Probiotics Antimicrob Proteins. 2025; .

PMID: 40072821 DOI: 10.1007/s12602-025-10506-5.


Ectoin attenuates cortisone-induced skin issues by suppression GR signaling and the UVB-induced overexpression of 11β-HSD1.

Xu D, Wu Y J Cosmet Dermatol. 2024; 23(12):4303-4314.

PMID: 39222375 PMC: 11626367. DOI: 10.1111/jocd.16516.


Integrated In Vivo and In Vitro Evaluation of a Powder-to-Hydrogel, Film-Forming Polymer Complex Base with Tissue-Protective and Microbiome-Supportive Properties.

Banov D, Song G, Foraida Z, Tkachova O, Zdoryk O, Carvalho M Gels. 2024; 10(7).

PMID: 39057470 PMC: 11276563. DOI: 10.3390/gels10070447.

References
1.
Yeon M, Kim Y, Jung H, Jeoung D . Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Front Cell Dev Biol. 2020; 8:486. PMC: 7311641. DOI: 10.3389/fcell.2020.00486. View

2.
McKinney B, Lin C, Rahman T, Oh H, Lewis D, Tseng G . DNA methylation in the human frontal cortex reveals a putative mechanism for age-by-disease interactions. Transl Psychiatry. 2019; 9(1):39. PMC: 6351569. DOI: 10.1038/s41398-019-0372-2. View

3.
Wedeking A, Hagen-Euteneuer N, Gurgui M, Broere R, Lentzen G, Tolba R . A lipid anchor improves the protective effect of ectoine in inflammation. Curr Med Chem. 2013; 21(22):2565-72. DOI: 10.2174/0929867321666131228222730. View

4.
Wellmerling J, Rayner R, Chang S, Kairis E, Kim S, Sharma A . Targeting the EGFR-ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del. FASEB J. 2022; 36(5):e22270. PMC: 9009300. DOI: 10.1096/fj.202100458RRR. View

5.
Yamaga S, Murao A, Ma G, Brenner M, Aziz M, Wang P . Radiation upregulates macrophage TREM-1 expression to exacerbate injury in mice. Front Immunol. 2023; 14:1151250. PMC: 10164953. DOI: 10.3389/fimmu.2023.1151250. View